Targeting Aberrant Ncam (neural cell adhesion molecule; CD56) Expression in Acute Myeloid Leukemia

被引：1
|
作者：
Sasca, Daniel [1 ,2 ]
Schueler, Andrea [1 ]
Szybinski, Jakub [1 ]
Kriege, Oliver [1 ]
Kunz, Kerstin [1 ]
Fehr, Eva Marie [1 ]
Haehnel, Patricia [1 ]
Gebhardt, Wolf Henning [3 ]
Reid, Gerge [3 ]
Theobald, Matthias [1 ]
Bullinger, Lars [4 ]
Kindler, Thomas [1 ]
机构：
[1] Johannes Gutenberg Univ Mainz, Univ Med Ctr, D-55122 Mainz, Germany
[2] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England
[3] Inst Mol Biol, Mainz, Germany
[4] Univ Ulm, D-89069 Ulm, Germany
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
10.1182/blood.V126.23.311.311
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] The role of cell adhesion molecules, CD56/NCAM in particular, in tumor biology
    Zeromski, J
    Nyczak, E
    Dyszkiewicz, W
    ENDOCRINE DISRUPTERS AND CARCINOGENIC RISK ASSESSMENT, 2002, 340 : 188 - 193
  • [32] Neural cell adhesion molecule (CD56)-positive B cell lymphoma of the urinary bladder
    Kawasaki, Tomonori
    Suzuki, Masamichi
    Sato, Ayaka
    Yashima-Abo, Akiko
    Satoh, Takashi
    Kato, Renpei
    Kato, Yoichiro
    Obara, Wataru
    Shimoyama, Tadashi
    Ishida, Yoji
    Sugai, Tamotsu
    JOURNAL OF CLINICAL PATHOLOGY, 2016, 69 (01) : 89 - 92
  • [33] CD56 Expression in Acute Lymphoblastic Leukemia of Childhood
    Ryan, M.
    McGranahan, A.
    Liang, X.
    LABORATORY INVESTIGATION, 2011, 91 : 319A - 319A
  • [34] CD56 Expression in Acute Lymphoblastic Leukemia of Childhood
    Ryan, M.
    McGranahan, A.
    Liang, X.
    MODERN PATHOLOGY, 2011, 24 : 319A - 319A
  • [35] Targeting Aberrant Expression of CD81 Impacts Cell Adhesion and Migration, Drug Resistance and Prognosis of Acute Myeloid Leukemia
    Gonzales, Fanny
    Boyer, Thomas
    Peyrouze, Pauline
    Guihard, Soizic
    Roumier, Christophe
    Berthon, Celine
    Preudhomme, Claude
    Cheok, Meyling
    BLOOD, 2017, 130
  • [36] NEURAL CELL-ADHESION MOLECULE (CD56)-POSITIVE, T(8-21) ACUTE MYELOID-LEUKEMIA (AML, M-2) AND GRANULOCYTIC SARCOMA
    KRISHNAN, K
    ROSS, CW
    ADAMS, PT
    PEREIRA, A
    ROTH, MS
    ANNALS OF HEMATOLOGY, 1994, 69 (06) : 321 - 323
  • [37] Acute myeloid leukemia (AML) with CD56 expression - A very high incidence of CD56 expression in AML with t(8;21) in Taiwan.
    Hsiao, CH
    Tang, JL
    Yao, M
    Tsay, W
    Wang, CH
    Chen, YC
    Shen, MC
    Tien, HF
    BLOOD, 2000, 96 (11) : 190B - 191B
  • [38] Cerebellar myeloblastoma formation in CD7-positive neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia (M1)
    Hatano, Y
    Miura, I
    Horiuchi, T
    Hoshi, N
    Nanjou, H
    Masuda, H
    Miura, AB
    ANNALS OF HEMATOLOGY, 1997, 75 (03) : 125 - 128
  • [39] Cerebellar myeloblastoma formation in CD7-positive, neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia (M1)
    Y. Hatano
    I. Miura
    T. Horiuchi
    N. Hoshi
    H. Nanjou
    H. Masuda
    A. B. Miura
    Annals of Hematology, 1997, 75 : 125 - 128
  • [40] NCAM1 (CD56) As a Predictor of Response to Standard Intensive Induction in Newly Diagnosed Acute Myeloid Leukemia
    Saultz, Jennifer N.
    Rai, Manoj
    Kaempf, Andy
    Bastola, Sanjog
    Cho, Hyun
    Long, Nicola
    Lachowiez, Curtis A.
    Meyers, Gabrielle
    Leonard, Jessica T.
    Gandhi, Arpita
    Newell, Laura F.
    Hayes-Lattin, Brandon
    Maziarz, Richard T.
    Cook, Rachel J.
    Traer, Elie
    Swords, Ronan T.
    Tyner, Jeffrey W.
    BLOOD, 2024, 144 : 2859 - 2860
12345